酸丁酸对德克萨米他诱导的骨肌肉缩的缓解作用

相关实验视频

Updated: May 28, 2025

08:24

A Murine Model of Muscle Training by Neuromuscular Electrical Stimulation

Published on: May 9, 2012

20.9K

Xingchen Zhao¹, Mingqiang Zhu¹, Zifan Wang²

¹Innovative Institute of Animal Healthy Breeding, Zhongkai University of Agriculture and Engineering, Guangzhou, Guangdong, China.

Cell biology international

|February 12, 2025

概括

酸盐可以防止德克萨米他引起的肌肉质量损失. 它通过减少缩基因表达和激活关键细胞信号通路来起作用,为肌肉消耗条件提供了潜在的治疗策略.

科学领域:

生物化学生化学
细胞生物学细胞生物学
身体生理学身体生理学

背景情况:

葡萄糖皮质类药物负面调节骨肌肉质量,促进代谢.
短链脂肪酸,如酸盐,调节炎症反应和信号通路.
德克萨米他是一种葡萄糖皮质类药物,已知可诱导骨肌肉缩.

研究的目的:

研究甲酸盐对德克萨米他诱导的骨肌肉缩的预防作用.
为了阐明甲酸盐作用的潜在分子机制.
评估酸盐对肌管缩模型的影响.

主要方法:

使用了一种由德克萨米他诱导的骨肌肉缩的小鼠模型.
施用酸盐来评估其保护作用.
分析了E3泛素合酶 (Atrogin-1,MURF1) 的基因表达.
研究了AKT/mTOR信号通路的激活.
使用百日咳毒素检查了G蛋白结合受体的作用.

主要成果:

酸减轻了德克萨米他诱导的肌管缩.
观察到Atrogin-1和MURF1的基因表达减少.
证实了AKT/mTOR信号通路的激活.
百日咳毒素逆转了保护作用,涉及G蛋白结合受体.
在小鼠中,酸盐预处理减少了体重和肌肉质量损失.
发现了MURF1基因表达的降低和葡萄糖皮质体受体的核转位.

结论:

酸有效抑制与肌肉缩相关的基因的表达.
在动物模型中,它可以防止蛋白质分解和随后的肌肉质量损失.
该机制涉及激活AKT/mTOR通路和潜在的G蛋白结合受体.
酸显示出作为预防肌肉衰竭的治疗剂的潜力.

关键词:

德克萨米他是一种骨肌肉缩骨肌肉缩甲酸盐和甲酸盐的使用方法

相关概念视频

01:21

Skeletal Muscle Relaxants: Adverse Effects

332

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...

332

01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

653

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...

653

01:31

Skeletal Muscle Relaxants: Therapeutic Uses

462

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...

462

01:28

Classification of Skeletal Muscle Relaxants

2.4K

Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...

2.4K

01:21

Satellite Stem Cells and Muscular Dystrophy

1.9K

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...

1.9K

01:20

Myasthenia Gravis: Overview and Treatment

1.1K

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...